Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
EYPT Stock — EyePoint, Inc.
EyePoint, Inc. (EYPT)
Updated October 16, 2026.
EYPT is a Stock. Total return is -99.3% over the past 21.7 years, 965.0 points behind SPY at 865.7%.
EyePoint, Inc. is a biopharmaceutical company developing therapeutic treatments for serious retinal diseases, with a lead product candidate called DURAVYU currently in Phase 3 clinical trials for wet age-related macular degeneration and diabetic macular edema. The company's pipeline leverages its proprietary Durasert E technology platform for sustained intraocular drug delivery. This company does not currently distribute to shareholders and appeals to investors focused on biotechnology development and long-term capital appreciation rather than income generation.
EYPT dividend yield and income
Price as of 2026-10-16.
The payment date is 12/09/2020.
EYPT performance versus SPY
Price and return data through 2026-10-16.
Total return is -99.3% over the past 21.7 years, 965.0 points behind SPY at 865.7%. Over the past year its total return — price change plus distributions reinvested — is -74.1%. Its deepest 1-year drawdown was 84.1%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -13.3% | — |
| 3M | -77.1% | — |
| 6M | -79.8% | — |
| YTD | -83.6% | — |
| 1Y | -74.1% | — |
| 2Y CAGR | — | -48.50% |
| 3Y CAGR | — | -28.60% |
| 5Y CAGR | — | -23.50% |
| 10Y CAGR | — | -18.50% |
| Since inception (21.7 years) | -99.3% | -20.20% |
EYPT key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 01/27/2005
- Distribution frequency
- None
- Last close
- $2.99 (as of 2026-10-16)
- Market cap
- $250,685,481
- Average volume
- 2750525.0
- Payment date
- 12/09/2020
- Beta
- 1.683
- Payout ratio
- 0.0%
- Forward P/E
- 6.1614
- EPS
- $-3.68
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
EYPT risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 84.1%.
Who may consider EYPT — and who may not
It is a weaker fit for investors who need monthly cash flow (EYPT does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on EYPT
Frequently asked questions
Does EYPT pay monthly?
No. EYPT does not currently distribute.
When does EYPT pay a dividend?
EYPT does not currently distribute. The payment date is 12/09/2020.
How has EYPT performed?
Total return is -99.3% over the past 21.7 years, 965.0 points behind SPY at 865.7%. Over the past year its total return — price change plus distributions reinvested — is -74.1%. Its deepest 1-year drawdown was 84.1%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.